The document provides an overview of various classifications of antidepressants, including reversible MAO-A inhibitors, tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and atypical antidepressants. It details their mechanisms of action, highlighting how some enhance neurotransmission while others influence receptor activity. Additionally, it discusses the role of bupropion and mirtazapine in managing cravings and improving neurotransmission.
Related topics: